Search for: "In Interest of BLA"
Results 61 - 80
of 109
Sorted by Relevance
|
Sort by Date
27 Feb 2023, 7:04 am
Mary Newchurch-in-Pendle [2023] ECC Bla 1] [Top of section] [Top of post] Other building works, including re-roofing Re St. [read post]
22 Mar 2024, 9:07 am
Unauthorized Transactions Unauthorized trading can be a serious violation of the broker’s duty to act in your best interests. [read post]
7 Sep 2016, 4:25 pm
The blasé assurance that privacy will be protected from hackers by “strict laws” reveals a fundamental misunderstanding of how vulnerable personal data is to theft and loss, the inevitability of function creep, and the deeper civic implications of this kind of system. [read post]
20 Feb 2017, 5:36 pm
MHRC held back 7.5% of the amounts payable to Falcon Creek as mandated by the Manitoba Builders’ Lien Act (BLA). [read post]
25 Jul 2013, 4:30 am
In an interesting twist, the real perpetrator cited their reason for making the threats as a way “to expose the police and prosecutors’ abomination. [read post]
20 Jul 2016, 2:44 pm
It is perhaps the most famous example of factory owners’ generally blasé attitude toward employee safety. [read post]
18 Jan 2018, 11:00 am
But the bigger problem lies in Darshan-Leitner and Katz’s blasé attitude toward the strategic and moral dimensions of the project they champion. [read post]
12 Dec 2017, 4:00 am
Blas, an Alabama magistrate judge not only reached the same result as in Trujillo-Alvarez but also devoted a portion of the opinion to establishing a clear rule for “all future cases. [read post]
27 Sep 2023, 7:51 pm
So, it will be interesting to see whether FDA’s practices change given how their own guidance explicitly includes those very topics as within the scope of an INTERACT meeting. [read post]
27 Feb 2024, 7:08 pm
Patent No. 7,829,531 with respect to BLA 125399 and U.S. [read post]
2 May 2024, 6:25 pm
One of the most interesting aspects of the final rule is the exemptions that FDA established. [read post]
2 Sep 2022, 12:30 am
The recently published Removal of bells from a closed church considers two judgments relating to St James, Church Kirk in the Blackburn Diocese; the earlier case, Re St James Church Kirk [2019] ECC Bla 4, suggested that the designation of “church treasure” was not appropriate in relation to one of the church’s bells [12, 13]. [read post]
12 Oct 2020, 6:30 am
I think that Wegman is just too blasé about such realities. [read post]
18 Feb 2024, 4:29 am
Since one of the two remaining objectors subsequently left the Church of England and did not respond to the Petitioners’ application, he too was no longer deemed to have “sufficient interest”. [read post]
21 May 2010, 7:18 am
We can’t use a model that sets our financial interests in opposition to our clients’ anymore. [read post]
13 Feb 2009, 8:19 pm
It calls for a variety of administrative or regulatory initiatives in the interest of child safety, such as the creation of the National Child Abuse Registry. [read post]
28 Apr 2015, 9:14 am
Congress carefully balanced the interests between sponsors and applicants, determined what the consequences should be at each step of the process for not completing it, and allowed the parties to weigh the benefits of proceeding against the consequences of not. [read post]
10 Feb 2012, 1:09 am
Draft Guidance No. 1 – Biosimilars: Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009: This draft guidance document is intended to provide answers to common questions from sponsors interested in developing proposed biosimilar products. [read post]
4 Apr 2023, 12:58 pm
As it further develops its approach to R&D costs, CMS should not fail to recognize that the costs of developing and accessing these platform technologies must be recognized and that they are not NDA/BLA or single manufacturer specific. [read post]
4 Sep 2020, 11:44 am
Depending on the type of product, the manufacturer may seek approval through various application processes, including New Drug Applications (NDA, for drugs), Biologic License Applications (BLA, for vaccines), New Molecular Entity applications (NME, for new active ingredients), or Premarket Approval applications (PMA, for devices). [read post]
